Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. [electronic resource]
Producer: 20060927Description: 597-604 p. digitalISSN:- 0923-7534
- Breast Neoplasms -- metabolism
- Cohort Studies
- Female
- Humans
- Inhibitor of Apoptosis Proteins
- Microtubule-Associated Proteins -- metabolism
- Neoplasm Proteins -- metabolism
- Plasminogen Activator Inhibitor 1 -- metabolism
- Receptor, ErbB-2 -- metabolism
- Survivin
- Treatment Outcome
- Urokinase-Type Plasminogen Activator -- metabolism
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.